Drug manufacturer Merck today extended its restrictions on 340B pricing involving contract pharmacies to community health centers. The restrictions have applied only to hospital covered entities until now.
Other grantee covered entities remain exempt “at this time,” Merck said, adding that “we will continue to evaluate our 340B program integrity initiative to determine if further updates may be warranted.”
Drug manufacturer Merck today extended its restrictions on 340B pricing involving contract pharmacies to community health centers.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
